InvestorsHub Logo
Followers 72
Posts 9170
Boards Moderated 0
Alias Born 09/30/2006

Re: None

Thursday, 05/06/2021 8:06:06 AM

Thursday, May 06, 2021 8:06:06 AM

Post# of 36541
Quote: "Ecomike you are absolutely right. Moving on to severe cases is risky and questionable"


This manufactured concern about the new USCF/RVV study is so phony it's actually laughable.

Honest criticism of RVV I have no issue with but these comments are just ridiculous when the actual facts are examined.

The PR clearly states in the first paragraph that it's a SPONSORED study to conduct PRE-CLINICAL TESTS and DESIGN PROTOCOLS for potential Trial submissions to the FDA.

Clearly it shows that it will not cost RVV a dime, is not even at the stage where the FDA will become involved AND it has and will have absolutely NOTHING to do with the ongoing Mild to Mod Trials.

If this severe study was to be incorporated with the current M2M Trial such a decision to alter the Protocols/Endpoints would have to be authorized by the DSMB and the FDA.

So in other words if such is the case and the Trial is delayed/hampered, the blame should fall primarily on the DSMB and the FDA because they are the ones who will ultimately have the final say.

I personally see no issue with RVV and the USCF exploring additional avenues where Buc could be applied in treating Covid or any future Flu outbreaks that may present itself.

Covid will definitely not be the last so the more "ammo" developed now against these viruses, the better prepared we'll be next time.......hopefully!

WELCOME TO UNICORNLAND